CBSC (Cardiac Biotech Solutions) Accounts Payable: $0.05 Mil (As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Cardiac Biotech Solutions Accounts Payable?

Cardiac Biotech Solutions CBSC Accounts Payable is $0.05 Mil as of Jun. 2025.

Cardiac Biotech Solutions's Accounts Payable for the quarter that ended in Jun. 2025 was $0.05 Mil.

Cardiac Biotech Solutions's quarterly Accounts Payable increased from Sep. 2024 ($0.04 Mil) to Mar. 2025 ($0.07 Mil) but then declined from Mar. 2025 ($0.07 Mil) to Jun. 2025 ($0.05 Mil).

Cardiac Biotech Solutions's annual Accounts Payable increased from Mar. 2023 ($0.02 Mil) to Mar. 2024 ($0.03 Mil) and increased from Mar. 2024 ($0.03 Mil) to Mar. 2025 ($0.07 Mil).

Cardiac Biotech Solutions Accounts Payable Related Terms

Cardiac Biotech Solutions Accounts Payable Historical Data

* Premium members only.

The historical data trend for Cardiac Biotech Solutions's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cardiac Biotech Solutions Accounts Payable Chart

Cardiac Biotech Solutions Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Accounts Payable
0.01 0.01 0.02 0.03 0.07

Cardiac Biotech Solutions Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.02 0.04 0.07 0.05

Cardiac Biotech Solutions Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0.05 Mil mean?
Cardiac Biotech Solutions (CBSC) has a Accounts Payable of $0.05 Mil as of Jun. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Cardiac Biotech Solutions and its competitors.
Is Cardiac Biotech Solutions' Accounts Payable too high?
Cardiac Biotech Solutions' current Accounts Payable is $0.05 Mil.
How does Cardiac Biotech Solutions' Accounts Payable compare to LUCY and NXGL?
Cardiac Biotech Solutions' Accounts Payable of $0.05 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Devices & Instruments company?
A good Accounts Payable depends on the Medical Devices & Instruments industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Cardiac Biotech Solutions and its competitors. Cardiac Biotech Solutions's current Accounts Payable is $0.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cardiac Biotech Solutions stock overvalued right now?
Cardiac Biotech Solutions (CBSC) has a current Accounts Payable of $0.05 Mil. The current Accounts Payable is $0.05 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Cardiac Biotech Solutions (CBSC), the current Accounts Payable is $0.05 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cardiac Biotech Solutions Business Description

Address 10845 Griffith Peak Drive, Suite 200, Las Vegas, NV, USA, 89135
Cardiac Biotech Solutions Inc, through its U.S. and international subsidiaries, provides products and services in the ambulatory non-invasive cardiac monitoring space. The FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, provide improved compliance for patients at risk of abnormal heart rhythms as well as more accurate information for physicians.